/ Side by side
Ipamorelin vs CJC-1295
A neutral, side-by-side look at Ipamorelin and CJC-1295: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Ipamorelin
Full profile →CJC-1295
with DAC · mod GRF 1-29
Full profile →| Attribute | Ipamorelin | CJC-1295 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Half-life | ~2 h, subcutaneous | With DAC ~6-8 days; without DAC |
| Common vial | 5, 10 mg | 2, 5, 10 mg |
| Reference | Verified | Verified |
What is Ipamorelin?
A selective ghrelin/growth-hormone-secretagogue receptor (GHS-R1a) agonist pentapeptide that stimulates pituitary growth hormone release with minimal effect on cortisol or prolactin.
Sources
- Raun et al., Eur J Endocrinol 1998
- Ishida et al. 2020 (GHS review)
What is CJC-1295?
A synthetic growth-hormone-releasing hormone (GHRH) analog that binds pituitary GHRH receptors to stimulate growth hormone secretion. The DAC (drug affinity complex) version binds albumin for a much longer half-life than the unmodified peptide.
Sources
- Teichman et al., J Clin Endocrinol Metab 2006
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.